Eelko Hak

PhD, Professor of Clinical Pharmacoepidemiology
Groningen Research Institute of Pharmacy, Unit of Pharmacotherapy, -Epidemiology and Economy, University of Groningen, Groningen, the Netherlands.
Groningen, Groningen, Netherlands

Presentation(s):

• OC 40.4 - Effect of previous INR control on subsequent DOAC persistence and adherence, in patients switched from VKA to DOAC

  Monday, June 26, 2023
  15:30 – 15:45 ET